231.68
Veeva Systems Inc stock is traded at $231.68, with a volume of 2.16M.
It is down -3.32% in the last 24 hours and down -1.13% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$239.64
Open:
$236.07
24h Volume:
2.16M
Relative Volume:
1.80
Market Cap:
$37.61B
Revenue:
$2.75B
Net Income/Loss:
$714.14M
P/E Ratio:
53.51
EPS:
4.33
Net Cash Flow:
$1.09B
1W Performance:
+6.06%
1M Performance:
-1.13%
6M Performance:
+3.47%
1Y Performance:
+1.73%
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
VEEV
Veeva Systems Inc
|
231.68 | 37.61B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
SOLV
Solventum Corp
|
75.89 | 13.13B | 8.26B | 66.00M | 1.17B | 0.3682 |
![]()
DOCS
Doximity Inc
|
61.71 | 11.58B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
HQY
Healthequity Inc
|
95.74 | 8.30B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
TEM
Tempus Ai Inc
|
45.58 | 7.85B | 640.44M | -743.28M | -206.93M | -11.29 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-23-25 | Downgrade | Goldman | Buy → Sell |
Dec-20-24 | Initiated | Stephens | Overweight |
Dec-04-24 | Initiated | Mizuho | Outperform |
Nov-19-24 | Initiated | Scotiabank | Sector Perform |
Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
Aug-27-24 | Reiterated | Citigroup | Buy |
Jul-09-24 | Initiated | BTIG Research | Buy |
Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-13-23 | Initiated | Jefferies | Buy |
Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
Mar-17-23 | Downgrade | Truist | Buy → Hold |
Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
Dec-06-22 | Initiated | Cowen | Market Perform |
Dec-02-22 | Reiterated | Needham | Buy |
Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Jul-27-22 | Initiated | Oppenheimer | Outperform |
Jun-23-22 | Initiated | Goldman | Buy |
Jun-21-22 | Resumed | Guggenheim | Buy |
Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-28-22 | Initiated | Truist | Buy |
Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Oct-01-21 | Resumed | Stifel | Buy |
Sep-02-21 | Reiterated | BofA Securities | Buy |
Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
Sep-02-21 | Reiterated | Needham | Buy |
Sep-02-21 | Reiterated | UBS | Neutral |
Jul-21-21 | Initiated | Cowen | Outperform |
Mar-31-21 | Upgrade | UBS | Sell → Neutral |
Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
Oct-14-20 | Resumed | UBS | Sell |
Aug-28-20 | Reiterated | Needham | Buy |
Jul-23-20 | Initiated | FBN Securities | Outperform |
Jul-07-20 | Initiated | Stephens | Overweight |
Jun-08-20 | Initiated | Citigroup | Buy |
May-29-20 | Reiterated | Needham | Buy |
Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
Feb-19-20 | Initiated | Robert W. Baird | Outperform |
Feb-14-20 | Initiated | Piper Sandler | Overweight |
Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
Aug-28-19 | Reiterated | Needham | Buy |
Jun-07-19 | Initiated | Goldman | Neutral |
May-30-19 | Reiterated | BofA/Merrill | Buy |
May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Apr-17-19 | Reiterated | Needham | Buy |
Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
Veeva (VEEV) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Veeva Systems Inc. (VEEV): A Bull Case Theory - Insider Monkey
Boehringer Ingelheim Partners With Veeva To Launch 'One Medicine Platform' -March 11, 2025 at 07:03 am EDT - Marketscreener.com
Veeva Powers Boehringer's Game-Changing One Medicine Platform for Drug Development - StockTitan
Veeva Systems Inc. (NYSE:VEEV) Stock Position Decreased by Mutual of America Capital Management LLC - Defense World
Veeva Systems (NYSE:VEEV) Surges 10% After Strong Earnings Report - Yahoo Finance
Scotiabank Forecasts Strong Price Appreciation for Veeva Systems (NYSE:VEEV) Stock - Defense World
Regulatory Information Management Software Market to See Revolutionary Growth: Sparta Systems, Veeva Systems - openPR
Veeva Systems Inc. (NYSE:VEEV) Just Released Its Yearly Earnings: Here's What Analysts Think - Simply Wall St
Robert W. Baird Forecasts Strong Price Appreciation for Veeva Systems (NYSE:VEEV) Stock - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Veeva Systems (NYSE:VEEV) - Defense World
Veeva Systems (NYSE:VEEV) Earns “Overweight” Rating from Stephens - Defense World
Veeva Systems (NYSE:VEEV) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Defense World
Biotech Stocks To Follow Now – March 6th - Defense World
Veeva Systems Inc. (NYSE:VEEV) Q4 2025 Earnings Call Transcript - MSN
VEEV Stock Gains Following Latest Availability of HCP Access Data - Nasdaq
Veeva price target raised to $245 from $240 at Scotiabank - Yahoo Finance
Veeva Systems: Solid Q4 With Margin Expansion (NYSE:VEEV) - Seeking Alpha
Veeva Systems (NYSE:VEEV) Shares Gap Up on Analyst Upgrade - Defense World
Veeva Systems Inc Class A to Host Earnings Call - ACCESS Newswire
Veeva Systems’ Earnings Call Highlights Strong Growth and Strategic Wins - TipRanks
Veeva Systems, Eli Lilly, Zscaler Among 16 New Names On IBD 50 Hot List - Investor's Business Daily
Why Veeva Systems (VEEV) Is Rallying Today - MSN
Veeva Systems (VEEV) Stock Trades Up, Here Is Why - Barchart
Why Veeva Systems Stock Is Surging Today - Mitrade
BJ's Wholesale Club Posts Better-Than-Expected Earnings, Joins Burlington Stores, Veeva Systems And Other Big Stocks Moving Higher On Thursday - Benzinga India
Why Veeva Systems Stock Is Surging Today - The Motley Fool
Citi maintains Veeva stock Buy rating, $307 target post Q4 beat - Investing.com India
Stifel maintains Veeva stock Buy rating, $272 target post-earnings - Investing.com India
Market Whales and Their Recent Bets on VEEV Options - Benzinga
Citi Reiterates Buy Rating on Veeva Systems (VEEV) - StreetInsider.com
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo Finance
Stifel maintains Veeva stock Buy rating, $272 target post-earnings By Investing.com - Investing.com UK
Veeva Earnings: Finishes the Year on a Strong Note With a Robust Growth Outlook - Morningstar
Veeva stock price target raised to $261 at TD Cowen - Investing.com India
Veeva stock price target raised to $261 at TD Cowen By Investing.com - Investing.com UK
RBC Capital maintains Veeva Systems outperform rating, $285 price target By Investing.com - Investing.com UK
RBC Capital maintains Veeva Systems outperform rating, $285 price target - Investing.com
VEEV Stock Up as Q4 Earnings & Revenues Beat Estimates, Margin Rise - TradingView
Veeva price target raised to $217 from $210 at Truist - TipRanks
Evercore ISI raises Veeva Systems target to $250 on strong Q4 - Investing.com India
Truist lifts Veeva Systems stock target to $217, retains hold - Investing.com India
Beyond The Numbers: 9 Analysts Discuss Veeva Systems Stock - Benzinga
Veeva Systems: Strong Financial Performance and Strategic Growth Drive Buy Rating - TipRanks
Veeva Systems: Strong Buy Rating Backed by Impressive Financial Performance and Strategic Positioning - TipRanks
Raymond James cuts Veeva Systems price target to $285 - Investing.com India
Veeva Systems (VEEV) PT Raised to $217 at Truist Securities - StreetInsider.com
Veeva price target raised to $201 from $195 at Morgan Stanley - TipRanks
Veeva Systems (VEEV) PT Raised to $250 at Evercore ISI - StreetInsider.com
Veeva Systems Sees Stock Surge with Strong Future ProjectionsNews and Statistics - IndexBox, Inc.
Veeva Systems A earnings beat by $0.16, revenue topped estimates - Investing.com South Africa
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):